OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Highlighted
Trial protocol
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Categories:
Model
118 Publications
found
EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong – A cost-effectiveness analysis.
b
PloS one
January 1, 2021
p
Cancer
c
Economics
Model
The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
b
PloS one
January 1, 2021
p
HIV POCT
c
Economics
Model
Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy.
b
The Journal of pediatrics
December 1, 2020
p
Newborn Screening
c
Economics
Model
Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
b
JAMA network open
December 1, 2020
p
Newborn Screening
c
Economics
Highlighted
Model
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study.
b
The Lancet. Infectious diseases
December 1, 2020
p
COVID-19
c
Clinical outcomes
Model
The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism.
b
International journal of neonatal screening
November 20, 2020
p
Newborn Screening
c
Economics
Model
Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa.
b
EClinicalMedicine
November 1, 2020
p
HIV POCT
c
Economics
Model
The potential for quality assurance systems to save costs and lives: the case of early infant diagnosis of HIV.
b
Tropical medicine & international health : TM & IH
October 1, 2020
p
HIV POCT
c
Economics
Model
Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
b
Journal of acquired immune deficiency syndromes (1999)
July 1, 2020
p
HIV POCT
c
Economics
Model
The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China.
b
BMJ global health
July 1, 2020
p
COVID-19
c
Economics
Model
Previous Page
1
…
4
5
6
7
8
…
12
Next Page
